Randomized controlled trial and open-label extension study designs.... | Download Scientific Diagram
Use Extension Studies To Enhance Phase 3 Data
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine
Study design of BLISS-SC trial and subsequent open-label extension... | Download Scientific Diagram
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study - The Lancet Respiratory Medicine
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial - The Lancet Neurology
How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download
Understanding Clinical Trial Terminology: What is a Long-Term Extension or Open-Label Extension Study? - Concert Pharmaceuticals
Open Label Expansion – Athira Clinical Trials
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study - The Lancet
Summary of Other Studies, Open-Label Extensions - Clinical Review Report: Telotristat (Xermelo) - NCBI Bookshelf
InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa | Markets Insider
Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram
Flow chart showing the study design of the open-label extension phase... | Download Scientific Diagram
HUMIRA (adalimumab) Open Label Extension Clinical Trial
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial - The Lancet Rheumatology
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results - Journal of Allergy and Clinical Immunology
Spotlight on Open-Label Extension Studies
Update on the CENTAUR trial: open label extension data - MND Research Blog
Open-label Extension Analysis – OCALIVA® (obeticholic acid) | Official US HCP Site
Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial - Devinsky - 2019 - Epilepsia - Wiley Online Library
Design of the lurasidone open-label core and extension switch studies.*... | Download Scientific Diagram
Overall study design of phase B (open-label extension) | Download Scientific Diagram
